Vaccine. 2009 Oct 23;27(45):6296-9.
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen...
4 results in 0.0399 seconds.
-
Giuseppe started a topic Vaccine. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.in VaccinesVaccine. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
-
Giuseppe started a topic J Virol. Non-replicating vaccinia vectors expressing the H5 influenza hemagglutinin produced in modified Vero cells induce robust protection.in VaccinesJ Virol. Non-replicating vaccinia vectors expressing the H5 influenza hemagglutinin produced in modified Vero cells induce robust protection.
J Virol. 2009 Mar 11. [Epub ahead of print]
Non-replicating vaccinia vectors expressing the H5 influenza hemagglutinin produced in modified Vero cells induce robust protection.
Mayrhofer J, Coulibaly S, Hessel A, Holzer G,... -
Giuseppe started a topic J Immunol. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice.in VaccinesJ Immunol. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice.
J Immunol. 2009 Mar 1;182(5):3063-71.
Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice.
Poon LL, Leung YH, Nicholls JM, Perera PY, Lichy JH,... -
Influenza and Pandemic Influenza: Are New Vaccines and Therapeuticals coming as current defense waning?
Bird flu vaccine production still lags-study | Reuters
Bird flu vaccine production still lags-study...
Tue Feb 24, 2009 10:02am EST
(recasts with quotes from WHO briefing)
By Stephanie Nebehay
GENEVA, Feb 24 (Reuters)